SKYE BIOSCIENCE INC.

Skye Bioscience to Participate in Upcoming Investment Conferences

22 May 2025 04:00:00 By Nasdaq GlobeNewswire

Skye Bioscience Establishes Partnership with Arecor Therapeutics to Develop Enhanced Formulation of Obesity Candidate Nimacimab

19 May 2025 02:00:49 By Nasdaq GlobeNewswire

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

13 May 2025 13:05:00 By Nasdaq GlobeNewswire

Skye Bioscience Clinical Model Demonstrating Necessity of Peripheral CB1 Inhibition for Weight Loss Presented at European Congress on Obesity

13 May 2025 04:00:00 By Nasdaq GlobeNewswire

Skye Bioscience Reports First Quarter 2025 Results and Highlights Nimacimab Differentiation in Obesity

08 May 2025 13:01:00 By Nasdaq GlobeNewswire

Skye Bioscience to Announce 2025 First Quarter Financial Results on May 8th, 2025

07 May 2025 04:00:00 By Nasdaq GlobeNewswire

Skye Bioscience to Participate in May Investment and Medical Conferences

29 Apr 2025 04:00:00 By Nasdaq GlobeNewswire

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

25 Apr 2025 17:06:26 By Nasdaq GlobeNewswire

Skye Bioscience Demonstrates Over 30% Weight Loss with Nimacimab and Tirzepatide Combination in Preclinical Model

15 Apr 2025 04:00:00 By Nasdaq GlobeNewswire

Skye Bioscience to Conduct Meetings at Piper Sandler Conference

14 Apr 2025 04:00:00 By Nasdaq GlobeNewswire

Skye Bioscience Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

20 Mar 2025 13:01:00 By Nasdaq GlobeNewswire

Skye Bioscience to Announce 2024 Financial Results on March 20th, 2025

14 Mar 2025 04:00:00 By Nasdaq GlobeNewswire

Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

27 Feb 2025 15:00:58 By Nasdaq GlobeNewswire

Skye Bioscience to Participate in SXSW Session on Obesity

24 Feb 2025 04:00:00 By Nasdaq GlobeNewswire

Skye Bioscience to Present at TD Cowen Health Care Conference

20 Feb 2025 04:00:00 By Nasdaq GlobeNewswire

Skye Bioscience Announces Participation in February Conferences

04 Feb 2025 04:00:00 By Nasdaq GlobeNewswire

Skye Bioscience Provides 2025 Look Ahead and Year in Review

13 Jan 2025 04:00:00 By Nasdaq GlobeNewswire

Skye Bioscience to Present at J.P. Morgan Healthcare Conference

19 Dec 2024 04:00:00 By Nasdaq GlobeNewswire

Skye Bioscience to Participate in Upcoming December Healthcare Investment Conferences

18 Nov 2024 04:00:00 By Nasdaq GlobeNewswire

Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor

14 Nov 2024 04:00:00 By Nasdaq GlobeNewswire